358 related articles for article (PubMed ID: 22688340)
1. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.
Breton M; Farret A; Bruttomesso D; Anderson S; Magni L; Patek S; Dalla Man C; Place J; Demartini S; Del Favero S; Toffanin C; Hughes-Karvetski C; Dassau E; Zisser H; Doyle FJ; De Nicolao G; Avogaro A; Cobelli C; Renard E; Kovatchev B;
Diabetes; 2012 Sep; 61(9):2230-7. PubMed ID: 22688340
[TBL] [Abstract][Full Text] [Related]
2. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
[TBL] [Abstract][Full Text] [Related]
3. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
4. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.
Kovatchev BP; Renard E; Cobelli C; Zisser HC; Keith-Hynes P; Anderson SM; Brown SA; Chernavvsky DR; Breton MD; Mize LB; Farret A; Place J; Bruttomesso D; Del Favero S; Boscari F; Galasso S; Avogaro A; Magni L; Di Palma F; Toffanin C; Messori M; Dassau E; Doyle FJ
Diabetes Care; 2014 Jul; 37(7):1789-96. PubMed ID: 24929429
[TBL] [Abstract][Full Text] [Related]
5. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
6. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
[TBL] [Abstract][Full Text] [Related]
7. Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.
Luijf YM; DeVries JH; Zwinderman K; Leelarathna L; Nodale M; Caldwell K; Kumareswaran K; Elleri D; Allen JM; Wilinska ME; Evans ML; Hovorka R; Doll W; Ellmerer M; Mader JK; Renard E; Place J; Farret A; Cobelli C; Del Favero S; Dalla Man C; Avogaro A; Bruttomesso D; Filippi A; Scotton R; Magni L; Lanzola G; Di Palma F; Soru P; Toffanin C; De Nicolao G; Arnolds S; Benesch C; Heinemann L;
Diabetes Care; 2013 Dec; 36(12):3882-7. PubMed ID: 24170747
[TBL] [Abstract][Full Text] [Related]
8. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
[TBL] [Abstract][Full Text] [Related]
9. Multinight "bedside" closed-loop control for patients with type 1 diabetes.
Brown SA; Kovatchev BP; Breton MD; Anderson SM; Keith-Hynes P; Patek SD; Jiang B; Ben Brahim N; Vereshchetin P; Bruttomesso D; Avogaro A; Del Favero S; Boscari F; Galasso S; Visentin R; Monaro M; Cobelli C
Diabetes Technol Ther; 2015 Mar; 17(3):203-9. PubMed ID: 25594434
[TBL] [Abstract][Full Text] [Related]
10. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
11. Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial.
Kovatchev BP; Kollar L; Anderson SM; Barnett C; Breton MD; Carr K; Gildersleeve R; Oliveri MC; Wakeman CA; Brown SA
Lancet Digit Health; 2020 Feb; 2(2):e64-e73. PubMed ID: 32864597
[TBL] [Abstract][Full Text] [Related]
12. Randomized Controlled Trial of Mobile Closed-Loop Control.
Kovatchev B; Anderson SM; Raghinaru D; Kudva YC; Laffel LM; Levy C; Pinsker JE; Wadwa RP; Buckingham B; Doyle FJ; Brown SA; Church MM; Dadlani V; Dassau E; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Lum J; Beck RW;
Diabetes Care; 2020 Mar; 43(3):607-615. PubMed ID: 31937608
[TBL] [Abstract][Full Text] [Related]
13. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
[TBL] [Abstract][Full Text] [Related]
15. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
[TBL] [Abstract][Full Text] [Related]
16. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D
Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
[TBL] [Abstract][Full Text] [Related]
17. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
Brown SA; Breton MD; Anderson SM; Kollar L; Keith-Hynes P; Levy CJ; Lam DW; Levister C; Baysal N; Kudva YC; Basu A; Dadlani V; Hinshaw L; McCrady-Spitzer S; Bruttomesso D; Visentin R; Galasso S; Del Favero S; Leal Y; Boscari F; Avogaro A; Cobelli C; Kovatchev BP
J Clin Endocrinol Metab; 2017 Oct; 102(10):3674-3682. PubMed ID: 28666360
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
19. Control to range for diabetes: functionality and modular architecture.
Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
